SHPHF (Sihuan Pharmaceutical Holdings Group) Total Liabilities: $671.8 Mil (As of Dec. 2025)

What is Sihuan Pharmaceutical Holdings Group Total Liabilities?

Sihuan Pharmaceutical Holdings Group SHPHF 51 Total Liabilities is $671.8 Mil as of Dec. 2025. GuruFocus rates SHPHF with a GF Score™ of 51/100 and a GF Value™ of $0.18 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Sihuan Pharmaceutical Holdings Group's Total Liabilities for the quarter that ended in Dec. 2025 was $671.8 Mil.

Sihuan Pharmaceutical Holdings Group's quarterly Total Liabilities increased from Dec. 2024 ($766.71 Mil) to Jun. 2025 ($791.19 Mil) but then declined from Jun. 2025 ($791.19 Mil) to Dec. 2025 ($671.81 Mil).

Sihuan Pharmaceutical Holdings Group's annual Total Liabilities declined from Dec. 2023 ($896.11 Mil) to Dec. 2024 ($766.71 Mil) and declined from Dec. 2024 ($766.71 Mil) to Dec. 2025 ($671.81 Mil).

Sihuan Pharmaceutical Holdings Group Total Liabilities Related Terms

Sihuan Pharmaceutical Holdings Group Total Liabilities Historical Data

* Premium members only.

The historical data trend for Sihuan Pharmaceutical Holdings Group's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sihuan Pharmaceutical Holdings Group Total Liabilities Chart

Sihuan Pharmaceutical Holdings Group Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Total Liabilities

Get a 7-Day Free Trial

839.27

932.45

896.11

766.71

671.81

Sihuan Pharmaceutical Holdings Group Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Total Liabilities	Get a 7-Day Free Trial															896.11	887.34	766.71	791.19	671.81

51GF Score

Sihuan Pharmaceutical Holdings Group Ltd SHPHF

Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Sihuan Pharmaceutical Holdings Group Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Sihuan Pharmaceutical Holdings Group's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	523.916	+	(104.296	+	43.6
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	671.8

Total Liabilities	=	Total Assets (A: Dec. 2025 )	-	Total Equity (A: Dec. 2025 )
	=	1651.512	-	979.7
	=	671.8

Sihuan Pharmaceutical Holdings Group's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	523.916	+	(104.296	+	43.6
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	671.8

Total Liabilities	=	Total Assets (Q: Dec. 2025 )	-	Total Equity (Q: Dec. 2025 )
	=	1651.512	-	979.7
	=	671.8

Frequently Asked Questions Learn more about Total Liabilities →

What does a Total Liabilities of $671.8 Mil mean?

Sihuan Pharmaceutical Holdings Group (SHPHF) has a Total Liabilities of $671.8 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Sihuan Pharmaceutical Holdings Group and its competitors.

Is Sihuan Pharmaceutical Holdings Group's Total Liabilities too high?

Sihuan Pharmaceutical Holdings Group's current Total Liabilities is $671.8 Mil. Overall, Sihuan Pharmaceutical Holdings Group has a GF Score™ of 51/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Sihuan Pharmaceutical Holdings Group's Total Liabilities compare to ZTS and UTHR?

Sihuan Pharmaceutical Holdings Group's Total Liabilities of $671.8 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Liabilities for a Drug Manufacturers company?

A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Liabilities mean?

A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Sihuan Pharmaceutical Holdings Group and its competitors. Sihuan Pharmaceutical Holdings Group's current Total Liabilities is $671.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Sihuan Pharmaceutical Holdings Group stock overvalued right now?

Based on GuruFocus' analysis, Sihuan Pharmaceutical Holdings Group (SHPHF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.18, compared to a current price of $0.13 — trading 27.9% below its estimated fair value. The current Total Liabilities is $671.8 Mil. Sihuan Pharmaceutical Holdings Group's overall GF Score™ is 51/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Liabilities calculated?

Total Liabilities is calculated from a company's financial statements. For Sihuan Pharmaceutical Holdings Group (SHPHF), the current Total Liabilities is $671.8 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sihuan Pharmaceutical Holdings Group (SHPHF) Overvalued in 2026?

Based on GuruFocus' analysis, Sihuan Pharmaceutical Holdings Group stock appears to be undervalued. The current stock price of $0.13 is trading 27.9% below its estimated GF Value™ of $0.18. GuruFocus considers Sihuan Pharmaceutical Holdings Group to be Modestly Undervalued.

Key valuation signals for SHPHF:

Total Liabilities: $671.8 Mil
GF Value™: $0.18 vs. price of $0.13 (27.9% below fair value)
GF Score™: 51/100 with 4 warning signs

No single metric tells the full story. See the SHPHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sihuan Pharmaceutical Holdings Group Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies HKSE:02186 HKSE:02652 HKSE:00570 HKSE:02575 HKSE:01349 HKSE:02005 HKSE:06185 HKSE:02877 HKSE:03613 HKSE:01681 XTER:MRK XSWX:GALD TSE:4502 SHSE:600276 NSE:SUNPHARMA LSE:HLN XTAE:TEVA XSWX:SDZ ZTS UTHR

Other Exchanges 00460:Hong Kong TEL1:Germany

Address 1 Harbour Road, Convention Plaza, Room 4905, Office Tower, Wanchai, HKG

Website https://www.sihuanpharm.com

Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the research & development and the manufacture & sale of pharmaceutical products. Its portfolio comprises products for diseases related to the cardio-cerebral vascular (CCV) system, Respiratory, Neurology, and others. The group has three reportable segments: the medical aesthetic products segment, including the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skincare, and others; the innovative medicine and other medicine segment; and the generic medicine segment, which generates key revenue. Geographically, the company generates a majority of its revenue from Mainland China and the rest from the United States.

51GF Score

Get the complete analysis for SHPHF

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.13

Price

$0.18

GF Value

View SHPHF Analysis

See Total Liabilities data for all stocks →